Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer

被引：0
|
作者：
Alluri, P. G. [1 ]
Larios, J. M. [1 ]
Malik, R. [1 ]
Hayes, D. F. [1 ]
Speers, C. W. [1 ]
Rae, J. M. [1 ]
Chinnaiyan, A. M. [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P6-12-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-12-05
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges
    Rej, Rohan Kalyan
    Thomas II, Junius Eugene
    Acharyya, Ranjan Kumar
    Rae, James Michael
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8339 - 8381
  • [32] Targeting Estrogen Receptor Alpha with Radiolabeled Estradiol for Breast Cancer Treatment
    Greene, Marianne
    Laina, Muriel
    Green, Bradley
    Corcoran, Emily
    Wu, Anhui
    Hanson, Robert N.
    Desombre, Eugene R.
    Greene, Geoffrey L.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [33] Resistance to endocrine therapy in breast cancer
    Kurebayashi, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (Suppl 1) : S39 - S46
  • [34] Resistance to endocrine therapy in breast cancer
    Junichi Kurebayashi
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 39 - 46
  • [35] Breast Cancer Chemoprevention: Targeting the Estrogen Receptor
    Chlebowski, Rowan T.
    Prabhaker, Radhika
    Tagawa, Tomoko
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (01) : 6 - 13
  • [36] Tracking endocrine resistance in estrogen-receptor positive breast cancer in ctDNA.
    Meissner, Magdalena
    Butler, Rachel
    Casbard, Angela Claire
    Carucci, Margherita
    Madden, Tracie-Ann
    Howell, Sacha Jon
    Jones, Robert Hugh
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Liu, Bo
    Ross, Dara S.
    Schram, Alison M.
    Razavi, Pedram
    Lagana, Stephen M.
    Zhang, Yanming
    Scaltriti, Maurizio
    Bromberg, Jacqueline F.
    Ladanyi, Marc
    Hyman, David M.
    Drilon, Alexander
    Zahir, Ahmet
    Benayed, Ryma
    Hechtman, Jaclyn F.
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Characterizing hormone therapy-resistance phenotypes in metastatic breast cancer conferred by estrogen receptor (ER) mutations
    Jia, Shanhang
    Hessenius, Ryan
    Ngo, Marilyn
    Wang, Peilu
    Bahreini, Amir
    Chen, Ning
    Ding, Zhijie
    Shun, Tong Ying
    Taylor, Lansing
    Puhalla, Shannon
    Lee, Adrian
    Oesterreich, Steffi
    Stern, Andrew M.
    CANCER RESEARCH, 2017, 77
  • [39] ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
    Reinert, Tomas
    Ramalho, Susana
    Antunes de Vasconcelos, Vivian Castro
    Silva, Leonardo Roberto
    Ribeiro da Silva, Ana Elisa
    de Andrade, Camila Annicchino
    de Paula Leite Kraft, Maria Beatriz
    Coelho, Guilherme Portela
    Mandelli, Jovana
    Binotto, Monique
    Cabello, Cesar
    de Paiva Silva, Geisilene Russano
    Bines, Jose
    Barrios, Carlos H.
    Ellis, Matthew J.
    Graudenz, Marcia Silveira
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] Abbreviated endocrine therapy duration for low estrogen receptor-positive breast cancer: The counter to extended endocrine therapy
    Poterala, Johanna E.
    Wisinski, Kari B.
    CANCER, 2022, 128 (09) : 1724 - 1726
12345